LMNA cardiomyopathy: Cell biology and genetics meet clinical medicine

DMM Disease Models and Mechanisms

Volumn 4, Issue 5, 2011, Pages 562-568

  Lu, Jonathan T ^a   Muchir, Antoine ^a   Nagy, Peter L ^a   Worman, Howard J ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A TYPE NUCLEAR LAMIN; LAMIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CLINICAL MEDICINE; CYTOLOGY; DEFIBRILLATOR; DISEASE COURSE; DNA SEQUENCE; FATALITY; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; GENETICS; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART INJURY; HUMAN; LAMINOPATHY; MISSENSE MUTATION; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

ANIMALS; BIOMEDICAL RESEARCH; CARDIOMYOPATHY, DILATED; CLINICAL MEDICINE; DISEASE MODELS, ANIMAL; HUMANS; LAMIN TYPE A; NUCLEAR LAMINA;

EID: 80052294217     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.006346     Document Type: Review

References (42)

1. Aebi, U., Cohn, J., Buhle, L. and Gerace, L. (1986). The nuclear lamina is a meshwork of intermediate-type filaments. Nature 323, 560-564. (Pubitemid 16025383)
2. Arbustini, E., Pilotto, A., Repetto, A., Grasso, M., Negri, A., Diegoli, M., Campana, C., Scelsi, L., Baldini, E., Gavazzi, A. et al. (2002). Autosomal dominant dilated cardiomyopathy with atrioventricular block:A lamin A/C defect-related disease. J. Am. Coll. Cardiol. 39, 981-990. (Pubitemid 34234120)
3. Arimura, T., Helbling-Leclerc, A., Massart, C., Varnous, S., Niel, F., Lacène, E., Fromes, Y., Toussaint, M., Mura, A. M., Keller, D. I. et al. (2005). Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum. Mol. Genet. 14, 155-169.
4. Bione, S., Maestrini, E., Rivella, S., Mancini, M., Regis, S., Romeo, G. and Toniolo, D. (1994). Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat. Genet. 8, 323-327.
5. Bonne, G., Di Barletta, M. R., Varnous, S., Bécane, H. M., Hammouda, E. H., Merlini, L., Muntoni, F., Greenberg, C. R., Gary, F., Urtizberea, J. A. et al. (1999). Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21, 285-288.
6. Bonne, G., Mercuri, E., Muchir, A., Urtizberea, A., Bécane, H. M., Recan, D., Merlini, L., Wehnert, M., Boor, R., Reuner, U. et al. (2000). Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann. Neurol. 48, 170-180. (Pubitemid 30617035)
7. Brodsky, G. L., Muntoni, F., Miocic, S., Sinagra, G., Sewry, C. and Mestroni, L. (2000). Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101, 473-476. (Pubitemid 30080859)
8. Dauer, W. T. and Worman, H. J. (2009). The nuclear envelope as a signaling node in development and disease. Dev. Cell 17, 626-638.
9. Davies, B. S., Fong, L. G., Yang, S. H., Coffinier, C. and Young, S. G. (2009). The posttranslational processing of prelamin A and disease. Annu. Rev. Genomics Hum. Genet. 10, 153-174.
10. Davies, B. S., Coffinier, C., Yang, S. H., Barnes, R. H., Jung, H. J., Young, S. G. and Fong, L. G. (2011). Investigating the purpose of prelamin A processing. Nucleus 2, 4-9.
11. Decaudain, A., Vantyghem, M. C., Guerci, B., Hécart, A. C., Auclair, M., Reznik, Y., Narbonne, H., Ducluzeau P. H., Donadille, B., Lebbé, C. et al. (2007). New metabolic phenotypes in laminopathies:LMNA mutations in patients with severe metabolic syndrome. J. Clin. Endocrinol. Metab. 92, 4835-4844. (Pubitemid 350223467)
12. Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D. K., Solimando, L. and Goldman, R. D. (2008). Nuclear lamins:Major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 22, 832-853. (Pubitemid 351482836)
13. De Sandre-Giovannoli, A., Chaouch, M., Kozlov, S., Vallat, J. M., Tazir, M., Kassouri, N., Szepetowski, P., Hammadouche, T., Vandenberghe, A., Stewart, C. L. et al. (2002). Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70, 726-736. (Pubitemid 34177926)
14. De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C. L., Munnich, A., Le Merrer, M. et al. (2003). Lamin a truncation in Hutchinson-Gilford progeria. Science 300, 2055. (Pubitemid 36760124)
15. Dhe-Paganon, S., Werner, E. D., Chi, Y. I. and Shoelson, S. E. (2002). Structure of the globular tail of nuclear lamin. J. Biol. Chem. 277, 17381-17384. (Pubitemid 34967536)
16. Di Barletta, R., Ricci, E., Galluzzi, G., Tonali, P., Mora, M., Morandi, L., Romorini, A., Voit, T., Orstavik, K. H., Merlini, L. et al. (2000). Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 66, 1407-1412. (Pubitemid 30468795)
17. Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P. et al. (2003). Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293-298. (Pubitemid 40852699)
18. Fatkin, D., MacRae, C., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H. J., Jr, Spudich, S., De Girolami, U. et al. (1999). Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341, 1715-1724.
19. Fisher, D. Z., Chaudhary, N. and Blobel, G. (1986). cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc. Natl. Acad. Sci. USA 83, 6450-6454. (Pubitemid 17174752)
20. Krimm, I., Östlund, C., Gilquin, B., Couprie, J., Hossenlopp, P., Mornon, J. P., Bonne, G., Courvalin, J. C., Worman, H. J. and Zinn-Justin, S. (2002). The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10, 811-823. (Pubitemid 34628710)
21. Lammerding, J., Schulze, P. C., Takahashi, T., Kozlov, S., Sullivan, T., Kamm, R. D., Stewart, C. L. and Lee, R. T. (2004). Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J. Clin. Invest. 113, 370-378. (Pubitemid 38544181)
22. Lin, F. and Worman, H. J. (1993). Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268, 16321-16326. (Pubitemid 23229934)
23. McKeon, F. D., Kirschner, M. W. and Caput, D. (1986). Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 319, 463-468. (Pubitemid 16212925)
24. McNair, W. P., Ku, L., Taylor, M. R., Fain, P. R., Dao, D., Wolfel, E., Mestroni, L. and Familial Cardiomyopathy Registry Research Group (2004). SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110, 2163-2167. (Pubitemid 39372495)
25. Meune, C., Van Berlo, J. H., Anselme, F., Bonne, G., Pinto, Y. M. and Duboc, D. (2006). Primary prevention of sudden death in patients with lamin A/C gene mutations. N. Engl. J. Med. 354, 209-210. (Pubitemid 43076737)
26. Muchir, A., Bonne, G., Van der Kooi, A. J., Van Meegen, M., Baas, F., Bolhuis, P. A., De Visser, M. and Schwartz, K. (2000). Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9, 1453-1459. (Pubitemid 30312494)
27. Muchir, A., Pavlidis, P., Bonne, G., Hayashi, Y. K. and Worman, H. J. (2007a). Activation of MAPK in hearts of EMD null mice:Similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum. Mol. Genet. 16, 1884-1895. (Pubitemid 47244536)
28. Muchir, A., Pavlidis, P., Decostre, V., Herron, A. J., Arimura, T., Bonne, G. and Worman, H. J. (2007b). Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J. Clin. Invest. 117, 1282-1293. (Pubitemid 46718416)
29. Muchir, A., Shan, J., Bonne, G., Lehnart, S. E. and Worman, H. J. (2009). Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum. Mol. Genet. 18, 241-247.
30. Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D'Apice, M. R., Massart, C., Capon, F., Sbraccia, P., Federici, M., Lauro, R. et al. (2002). Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 71, 426-431. (Pubitemid 34800259)
31. Parks, S. B., Kushner, J. D., Nauman, D., Burgess, D., Ludwigsen, S., Peterson, A., Li, D., Jakobs, P., Litt, M., Porter, C. B. et al. (2008). Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am. Heart J. 156, 161-169.
32. Pasotti, M., Klersy, C., Pilotto, A., Marziliano, N., Rapezzi, C., Serio, A., Mannarino, S., Gambarin, F., Favalli, V., Grasso, M. et al. (2008). J. Am. Coll. Cardiol. 52, 1250-1260.
33. Quijano-Roy, S., Mbieleu, B., Bönnemann, C. G., Jeannet, P. Y., Colomer, J., Clarke, N. F., Cuisset, J. M., Roper, H., De Meirleir, L., D'Amico, A. et al. (2008). De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann. Neurol. 64, 177-186.
34. Stewart, C. L., Kozlov, S., Fong, L. G. and Young, S. G. (2007). Mouse models of the laminopathies. Exp. Cell Res. 313, 2144-2156.
35. Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C. L. and Burke, B. (1999). Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147, 913-920.
36. Taylor, M. R., Fain, P. R., Sinagra, G., Robinson, M. L., Robertson, A. D., Carniel, E., Di Lenarda, A., Bohlmeyer, T. J., Ferguson, D. A., Brodsky, G. L. et al. (2003). Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J. Am. Coll. Cardiol. 41, 771-780. (Pubitemid 36308384)
37. Van Berlo, J. H., De Voogt, W. G., Van der Kooi, A. J., Van Tintelen, J. P., Bonne, G., Yaou, R. B., Duboc, D., Rossenbacker, T., Heidbüchel, H., De Visser, M. et al. (2005). Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations:Do lamin A/C mutations portend a high risk of sudden death? J. Mol. Med. 83, 79-83. (Pubitemid 40169500)
38. Van Engelen, B. G., Muchir, A., Hutchison, C. J., Van der Kooi, A. J., Bonne, G. and Lammens, M. (2005).The lethal phenotype of a homozygous nonsense mutation in the lamin A/C gene. Neurology 64, 374-376.
39. Voelkerding, K. V., Dames, S. and Durtschi, J. D. (2010). Next generation sequencing for clinical diagnostics-principles an application to targeted resequencing for hypertrophic cardiomyopathy:A paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn. 12, 539-551.
40. Wilson, K. L. and Foisner, R. (2010). Lamin-binding proteins. Cold Spring Harb. Perspect. Biol. 2, a000554.
41. Wu, W., Shan, J., Bonne, G., Worman, H. J. and Muchir, A. (2010). Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene. Biochim. Biophys. Acta 1802, 632-638.
42. Wu, W., Muchir, A., Shan, J., Bonne, G. and Worman, H. J. (2011). Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation 123, 53-61.